Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEMOXEL in Advanced Pancreatic Adenocarcinoma
NCT00744640Phase 2Completed
- Sponsor
- University Hospital Basel
- Start
- Oct 2005
- Primary completion
- Feb 2009
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, capecitabine in pancreatic adenocarcinoma (PDAC), sponsored by University Hospital Basel. Started Oct 2005; status: completed.
02
Drugs
oxaliplatincapecitabine
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00744640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00744640.